4.7 Review

Daptomycin for the treatment of acute bacterial meningitis: A narrative review

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Combination therapy for disseminated strongyloidiasis with associated vancomycin-resistant, linezolid-intermediate Enterococcus faecium meningitis: A case report

Morgan A. Tobin et al.

Summary: This case report describes a 61-year-old male patient who developed DS-associated VRE meningitis after receiving corticosteroids, and unfortunately passed away despite treatment. The use of combination therapy early on in DS-associated VRE meningitis patients may be beneficial for improving patient outcomes.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2022)

Review Pharmacology & Pharmacy

High-Dose Daptomycin and Clinical Applications

Timothy W. Jones et al.

Summary: High-dose daptomycin shows superior efficacy in serious gram-positive infections, particularly in endocarditis and bacteremia caused by MRSA and Enterococcus. Consideration of clearance modality is necessary for dosing in renal replacement therapy, and concerns exist regarding elevated exposures in obesity. Clinicians are encouraged to evaluate dosing standards for different infectious etiologies and patient populations.

ANNALS OF PHARMACOTHERAPY (2021)

Review Clinical Neurology

Acute bacterial meningitis

Emma C. Wall et al.

Summary: Community-acquired bacterial meningitis is a dynamic disease with evolving epidemiology and pathogenesis data. Early antibiotic administration is crucial for improving survival, while unnecessary cranial imaging causes diagnostic delays. New treatments such as C5 inhibitors and daptomycin are currently in clinical trials.

CURRENT OPINION IN NEUROLOGY (2021)

Review Pediatrics

Safety of ceftriaxone in paediatrics: a systematic review

Linan Zeng et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2020)

Article Microbiology

High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram

Matthieu Gregoire et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

Article Critical Care Medicine

Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis

S. Piva et al.

NEUROCRITICAL CARE (2019)

Article Immunology

Epidemiology of Meningitis in Canadian Neonatal Intensive Care Units

Walid El-Naggar et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2019)

Article Health Care Sciences & Services

Safety of high-dose daptomycin in patients with severe renal impairment

Chih-Hsun Tai et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)

Review Pharmacology & Pharmacy

The Nephrotoxicity of Vancomycin

E. J. Filippone et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)

Review Infectious Diseases

The negative impact of antibiotic resistance

N. D. Friedman et al.

CLINICAL MICROBIOLOGY AND INFECTION (2016)

Review Infectious Diseases

Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis

Konstantinos Z. Vardakas et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)

Review Public, Environmental & Occupational Health

Daptomycin-induced eosinophilic pneumonia - a systematic review

Priyasha Uppal et al.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2016)

Article Infectious Diseases

Mechanisms of drug resistance: daptomycin resistance

Truc T. Tran et al.

ANTIMICROBIAL THERAPEUTICS REVIEWS (2015)

Review Infectious Diseases

Vancomycin-resistant Enterococcus faecium meningitis in adults: Case series and review of the literature

Bettina M. Knoll et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)

Article Infectious Diseases

Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics

Marjolein P. M. Hensgens et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Article Microbiology

Pharmacokinetics of Single-Dose Daptomycin in Patients with Suspected or Confirmed Neurological Infections

Ravina Kullar et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

Article Infectious Diseases

Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia

Theodoros Kelesidis et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)

Article Health Care Sciences & Services

GRADE guidelines: 3. Rating the quality of evidence

Howard Balshem et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Pharmacology & Pharmacy

Cerebrospinal Fluid Penetration of High-Dose Daptomycin in Suspected Staphylococcus aureus Meningitis

M. Shawn Riser et al.

ANNALS OF PHARMACOTHERAPY (2010)

Letter Immunology

Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin

Dong Heun Lee et al.

CLINICAL INFECTIOUS DISEASES (2008)

Article Emergency Medicine

Acute bacterial meningitis

Sharon E. Mace

EMERGENCY MEDICINE CLINICS OF NORTH AMERICA (2008)

Review Pharmacology & Pharmacy

Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists

Vanthida Huang et al.

PHARMACOTHERAPY (2006)

Article Immunology

Early-onset Rhabdomyolysis Associated With Daptomycin

Charles M. Edwards et al.

INFECTIOUS DISEASES IN CLINICAL PRACTICE (2006)

Article Infectious Diseases

Dexamethasone treatment in adults with pneumococcal meningitis: risk factors for death

M Weisfelt et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)

Article Pediatrics

Diagnosis and treatment of bacterial meningitis

H El Bashir et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2003)

Article Microbiology

Hematologic effects of linezolid: Summary of clinical experience

SL Gerson et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)

Review Medicine, General & Internal

Cephalosporin allergy

PS Kelkar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)